1,2-Dioleoyl-3(R)-trimethylammoniumpropane (chloride)
CAY-38194-250 250 mg
Data Sheet: 
SDS:
SDS:
CAS
328250-28-8
Formulation
A solid
Purity
≥95%
MW
698,54164
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A cationic lipid; lipoplexes containing R-DOTAP and encapsulating siRNA targeting CYP19A1 decrease aromatase activity in MCF-7 cells; vaccination with an HPV 16 protein E7 peptide in R-DOTAP-containing liposomes induces IFN-γ production by CD8+ T cells and TILs and decreases tumor size in a murine cervical cancer model; subcutaneous immunization with recombinant influenza B hemagglutinin using R-DOTAP as an adjuvant increases IL-2 and IFN-γ production in CD4+ T cells isolated from mouse draining lymph nodes and spleen
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
